Oxford, UK – 23 January 2013: Oxford BioMedica plc (LSE: OXB), the leading gene-based biopharmaceutical company, will be announcing its preliminary results for the twelve months ended 31 December 2012 on Wednesday, 27 February 2013.
An analyst briefing will be held at 09:30am GMT on Wednesday, 27 February 2013 at the offices of M:Communications, 11th Floor, CityPoint, 1 Ropemaker Street, London, EC2Y 9AW. An audio replay will be made available shortly after the presentation on the Company’s website: www.oxfordbiomedica.co.uk.
-Ends-